+1 (347) 952-8676 info@curtiscoulter.com

Oral Peptide Therapeutics – Technologies have been honed to overcome many of the challenges of administering peptide therapeutics orally, but obstacles remain before drug developers can fully realize the vast potential.

Numerous technologies are currently in development that are designed to enable the oral delivery of peptides. Though each has its unique set of properties and capabilities, all must overcome key obstacles to successfully deliver peptides via the oral route.

This week’s available download is titled “Novel Approaches for Enhancing the Oral Bioavailability & Absorption of Peptides” from Rebecca Nofsinger at Merck. This presentation discusses peptide advantages and challenges, permeation enhancers and models to evaluate permeation limitations in oral absorption.

Scroll through the presentation below….

Our goal is to help you improve the performance of your drug products. The next generation of peptide drug and therapeutic delivery is here. Are you looking to improve the performance of your peptide drug products?

Hear from over 30 peptide drug commercialization experts and connect with 100’s of senior drug product development experts from pharma, biotech and speciality drug development organizations. 2021’s Summit will examine various peptide discovery and synthesis techniques and synthesized and modified peptides. Learn novel strategies for improving peptide stability and half-life, along with novel routes of administration, and walk away with over 2 years of new peptide commercialization strategies in just 2 days!

Register to attend today and walk away with game-changing development strategies which could decrease time-to-market and save you millions. Don’t miss your chance to attend 2021’s one-of-a-kind Summit at the lowest available registration rate!

Pin It on Pinterest

Share This

Share this with a friend or colleague!